Role of Glucagon-like Peptide-2 in Rodent Models of Colon Cancer

Role of Glucagon-like Peptide-2 in Rodent Models of Colon Cancer

Show other versions (1)

Glucagon-like peptide-2 (GLP-2) is an intestinotrophic and intestinal anti-inflammatory hormone. Hence, I hypothesized that treatment with degradation-resistant hGly2GLP-2 increases, while blocking endogenous GLP-2 decreases colorectal cancer (CRC) in rodents. In mice, treatment with dextran sodium...

Full description

Bibliographic Details
Main Author:	Trivedi, Shivangi
Other Authors:	Brubaker, Patricia
Language:	en_ca
Published:	2011
Subjects:	Glucagon-like peptide-2 Colon cancer 0719
Online Access:	http://hdl.handle.net/1807/31613

Similar Items

Role of Glucagon-like Peptide-2 in Rodent Models of Colon Cancer
by: Trivedi, Shivangi
Published: (2011)

Role of the Intestinal Epithelial Insulin-like Growth Factor-1 Receptor in Glucagon-like Peptide-2-mediated Small Intestinal Growth Responses
by: Rowland, Katherine Julie
Published: (2011)

Role of the Intestinal Epithelial Insulin-like Growth Factor-1 Receptor in Glucagon-like Peptide-2-mediated Small Intestinal Growth Responses
by: Rowland, Katherine Julie
Published: (2011)

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis
by: Panjwani, Naim
Published: (2012)

The Role of the Glucagon-like Peptide-1 Receptor in Atherosclerosis
by: Panjwani, Naim
Published: (2012)

The Effect of Insulin and Insulin Resistance on Glucagon-like Peptide-1 Secretion from the Intestinal L Cell
by: Lim, Gareth Eu-Juang
Published: (2009)

The Effect of Insulin and Insulin Resistance on Glucagon-like Peptide-1 Secretion from the Intestinal L Cell
by: Lim, Gareth Eu-Juang
Published: (2009)

Association of glucagon‐like peptide‐1 receptor‐targeted imaging probe with in vivo glucagon‐like peptide‐1 receptor agonist glucose‐lowering effects
by: Takaaki Murakami, et al.
Published: (2020-11-01)

Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1
by: Poreba, Monika
Published: (2011)

Role of Fatty Acid Transport Proteins in Oleic Acid-induced Secretion of Glucagon-like Peptide-1
by: Poreba, Monika
Published: (2011)

Glucagon-like peptide-1 and glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes
by: Seungah Lee, et al.
Published: (2017-03-01)

Evolution of glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes
by: Gagik R. Galstyan, et al.
Published: (2017-10-01)

Cardiovascular Effects of Glucagon-Like Peptide-1 Receptor Agonists
by: Yu Mi Kang, et al.
Published: (2016-06-01)

Diabetes and obesity. The role of agonists glucagon-like peptide-1 of in the treatment of type 2 diabetes
by: Nina A. Petunina, et al.
Published: (2018-10-01)

Expression of Glucagon-Like Peptide 1 Receptor during Osteogenic Differentiation of Adipose-Derived Stem Cells
by: Yun Kyung Jeon, et al.
Published: (2014-12-01)

Treatment with Glucagon-Like Peptide-1 Analogues — a Breakthrough in Diabetes Mellitus Type 2 Therapy
by: V.L. Orlenko, et al.
Published: (2014-05-01)

New Potential Targets of Glucagon-Like Peptide 1 Receptor Agonists in Pancreatic β-Cells and Hepatocytes
by: Won-Young Lee
Published: (2017-02-01)

Does Glucagon-Like Peptide-1 Have a Role in the Etiopathogenesis of Gestational Diabetes?
by: Mustafa Demirpençe, et al.
Published: (2016-06-01)

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity
by: Ekaterina V. Tikhonenko, et al.
Published: (2019-03-01)

The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes
by: Hadjiyianni, Irene Ioanna
Published: (2010)

The Role of Glucagon-like Peptides in Experimental Type 1 Diabetes
by: Hadjiyianni, Irene Ioanna
Published: (2010)

Glucagon‐like peptide‐1 receptor agonists for type 2 diabetes: A rational drug development
by: Bo Ahrén
Published: (2019-03-01)

Glucagon-like peptide 1 and dysglycemia: Conflict in incretin science
by: Awadhesh Kumar Singh
Published: (2015-01-01)

Expression of the glucagon-like peptide-1 receptor and its role in regulating autophagy in endometrial cancer
by: Ranka Kanda, et al.
Published: (2018-06-01)

Activation of overexpressed glucagon‐like peptide‐1 receptor attenuates prostate cancer growth by inhibiting cell cycle progression
by: Toru Shigeoka, et al.
Published: (2020-09-01)

The Impact of Glucagon-Like Peptide 1 Receptor Agonists on Bone Metabolism and Its Possible Mechanisms in Osteoporosis Treatment
by: Baocheng Xie, et al.
Published: (2021-06-01)

Glucagon-like peptide-1 analogues: An overview
by: Vishal Gupta
Published: (2013-01-01)

Glucagon-like peptide-1 receptor overexpression in cancer and its impact on clinical applications
by: Meike eKörner, et al.
Published: (2012-12-01)

Glucagon‐like peptide‐1 acutely affects renal blood flow and urinary flow rate in spontaneously hypertensive rats despite significantly reduced renal expression of GLP‐1 receptors
by: Jonas Ronn, et al.
Published: (2017-12-01)

Effects of exercise on glucagon-like peptide-1 (GLP-1)
by: Shin-ya Ueda, et al.
Published: (2013-06-01)

Glucagon-Like Peptide-1 Depots for the Treatment of Type-2 Diabetes
by: Amiram, Miriam
Published: (2012)

Glucagon-like peptide-1 receptor agonists in the treatment of type 2 diabetes: Past, present, and future
by: Sanjay Kalra, et al.
Published: (2016-01-01)

The deletion of glucagon-like peptide-1 receptors expressing neurons in the dorsomedial hypothalamic nucleus disrupts the diurnal feeding pattern and induces hyperphagia and obesity
by: Yuko Maejima, et al.
Published: (2021-06-01)

Glucagon-like peptide 2 (GLP-2) in bovine colostrum and transition milk
by: Yudai Inabu, et al.
Published: (2021-05-01)

The role of human glucagon-like peptide-1 analog in therapy of type 2 dianetes mellitus
by: Marina Vladimirovna Shestakova
Published: (2010-09-01)

Glucagon-Like Peptide-1
by: Joel P. Giblett, BM, BSc, et al.
Published: (2016-06-01)

The Effect of Glucagon-like Peptide-2 on Insulin-like Growth Factor-1 in Murine Intestinal Subepithelial Myofibroblasts
by: Leen, Jason
Published: (2009)

The Effect of Glucagon-like Peptide-2 on Insulin-like Growth Factor-1 in Murine Intestinal Subepithelial Myofibroblasts
by: Leen, Jason
Published: (2009)

Study of the serum level of fasting glucagon-like peptide-1 in type 2 diabetics and its relation to the glycemic profile
by: Mohamed A Korani, et al.
Published: (2018-01-01)

The Impact of Glucagon-Like Peptide-1 on Bone Metabolism and Its Possible Mechanisms
by: Chenhe Zhao, et al.
Published: (2017-05-01)